Provided by Tiger Trade Technology Pte. Ltd.

PAVmed

10.80
+0.22002.08%
Post-market: 10.950.1500+1.39%19:59 EST
Volume:363.83K
Turnover:4.06M
Market Cap:10.68M
PE:-1.62
High:11.30
Open:10.83
Low:10.38
Close:10.58
52wk High:28.44
52wk Low:6.00
Shares:989.06K
Float Shares:813.72K
Volume Ratio:0.82
T/O Rate:44.71%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-6.6481
EPS(LYR):99.15
ROE:17.44%
ROA:-36.78%
PB:1.26
PE(LYR):0.11

Loading ...

PAVmed tilgt ausstehende Wandelanleihen und Vorzugsaktien

Reuters
·
Feb 04

Press Release: PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities

Dow Jones
·
Feb 04

PAVmed trading halted, volatility trading pause

TIPRANKS
·
Feb 02

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Feb 02

PAVmed Regains Compliance with Nasdaq Minimum Bid Price

TIPRANKS
·
Jan 24

What's Going On With PAVmed Shares Thursday?

Benzinga
·
Jan 22

PAVmed trading resumes

TIPRANKS
·
Jan 21

NASDAQ TRADE HALT VOLATILITY TRADING PAUSE AT 09:37 AM

Reuters
·
Jan 21

Huge Win for Sends PAVmed (PAVM) Shares Surging

TIPRANKS
·
Jan 21

BUZZ-U.S. STOCKS ON THE MOVE-Teledyne, Arm Holdings, Nathan’s Famous

Reuters
·
Jan 21

PAVmed Subsidiary Lucid Diagnostics Wins US Department of Veterans Affairs Contract

MT Newswires Live
·
Jan 21

Why Are PAVmed (PAVM) & Lucid Diagnostics (LUCD) Stocks Up Today?

TIPRANKS
·
Jan 21

BUZZ-Lucid Diagnostics rises after winning VA contract for cancer test

Reuters
·
Jan 21

Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for Esoguard®

THOMSON REUTERS
·
Jan 21

BRIEF-PAVmed Announces Reverse Stock Split

Reuters
·
Dec 30, 2025

PAVmed Announces 1-for-30 Reverse Stock Split

Reuters
·
Dec 30, 2025

PAVmed Is Maintained at Buy by Ascendiant Capital

Dow Jones
·
Dec 10, 2025

PAVmed Inc : Ascendiant Capital Markets Cuts Target Price to $17 From $20

THOMSON REUTERS
·
Dec 10, 2025

PAVmed Shareholders Approve Reverse Stock Split and Share Reduction

Reuters
·
Dec 06, 2025

Pavmed Inc. Reports Q3 2025 Earnings and Strategic Focus

TIPRANKS
·
Nov 19, 2025